Mechanisms of Methicillin Resistance in Staphylcoccus aureus and Methods for Laboratory Detection
- 1 January 1991
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 12 (1), 14-19
- https://doi.org/10.1086/646233
Abstract
Three distinctly different mechanisms of methicillin resistance have been described in Staphylococcus aureus. The best-documented and probably most important mechanism is production of a unique, low affinity penicillin-binding protein, PBP 2a. Strains possessing PBP 2a are resistant to methicillin, oxacillin, and probably all other currently available beta-lactam antibiotics. Two additional mechanisms of reduced susceptibility to methicillin have been described. Borderline resistance (BORSA) to the semi-synthetic penicillins has been attributed to the hyperproduction of normal staphylococcal beta-lactamase. A third mechanism has recently been advanced that describes an intermediate level of resistance to methicillin due to production of modified, normal PBPs with reduced affinity for beta-lactams (MODSA). Little is known regarding the prevalence or clinical significance of the BORSA and MODSA strains. The most reliable in vitro susceptibility test methods for detecting MRSA (strains possessing PBP 2a) include the microdilution minimum inhibitory concentration (MIC) test (with 2% NaCl supplemented broth), the oxacillin agar screen plate test (incorporating 6 micrograms/ml oxacillin in 4% NaCl supplemented agar), and the National Committee for Clinical Laboratory Standards (NCCLS) disk diffusion test with oxacillin. All three methods use direct inoculum preparation and incubation of tests at 35 degrees C for a full 24 hours.Keywords
This publication has 38 references indexed in Scilit:
- Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1990
- Further characterization of borderline methicillin-resistant Staphylococcus aureus and analysis of penicillin-binding proteinsAntimicrobial Agents and Chemotherapy, 1990
- New mechanism for methicillin resistance in Staphylococcus aureus: clinical isolates that lack the PBP 2a gene and contain normal penicillin-binding proteins with modified penicillin-binding capacityAntimicrobial Agents and Chemotherapy, 1989
- Methicillin-resistant staphylococci: detection methods and treatment of infectionsAntimicrobial Agents and Chemotherapy, 1989
- Low-level methicillin resistance in strains of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1989
- Methicillin-resistant staphylococciClinical Microbiology Reviews, 1988
- Laboratory and epidemiologic experience with methicillin-resistantStaphylococcus aureus in the USAEuropean Journal of Clinical Microbiology & Infectious Diseases, 1986
- Expression of methicillin resistance in heterogeneous strains of Staphylococcus aureusAntimicrobial Agents and Chemotherapy, 1986
- Effectiveness of cefamandole against methicillin-resistant strains of Staphylococcus aureus in vitro and in experimental infectionsJournal of Antimicrobial Chemotherapy, 1984
- Clinical, epidemiologic and bacteriologic observations of an outbreak of methicillin-resistant staphylococcus aureus at a large community hospitalThe American Journal of Medicine, 1976